查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1832493

心臟復健设备市场：按产品类型、最终用户和服务 - 2025 年至 2032 年全球预测

Cardiac Rehabilitation Device Market by Product Type, End User, Service - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年心臟復健设备市场将成长至 48.7 亿美元，复合年增长率为 8.34%。

主要市场统计数据
基准年2024年 25.6亿美元
预计2025年 27.8亿美元
预测年份：2032年 48.7亿美元
复合年增长率（%） 8.34%

定义临床实践与相关復健技术的不断发展的交集，以重塑循环系统患者的康復途径

心臟復健技术处于医疗设备工程、数位健康和​​以患者为中心的护理的交叉领域。近期的技术创新週期使得持续的生理监测、有针对性的治疗性介入以及日益复杂的远端干预成为可能，将设备的覆盖范围扩展到了临床环境之外。数据分析、互通性标准和以使用者为中心的设计等领域的平行发展与这些进步相辅相成，共同重塑了循环系统团队在整个护理过程中提供復健服务的方式。

透过监测设备（例如门诊心电图和多参数平台）以及针对院外安全使用而优化的復健设备，復健模式已从以住院患者为中心的模式转变为融合诊所监管和家庭治疗方案的混合模式。同时，电刺激和呼吸治疗工具等治疗设备也正在被改造，以实现可扩展的、受监管的家庭使用。设备小型化、连接性和远端服务交付的融合，正在为提高依从性、减少再入院率以及根据个人康復轨迹调整康復强度开闢新的途径。

鑑于这些动态，从临床领导者到设备开发商的相关人员正在重新审视护理路径和筹资策略。付款人和医疗系统越来越关注能够证明临床结果和营运效率的证据。因此，心臟復健设备领域正在快速发展，影响临床通讯协定、采购决策和病患参与模式。

感测器聚合、紧凑型復健设备和不断发展的政策如何加速混合心臟復健模型和远端临床监测

由于技术的成熟、政策的演变以及医疗服务的重新设计，心臟復健设备的格局正在转变。在技​​术层面，感测器保真度、电池效率和即时分析的融合使监测设备能够提供具有临床意义的数据流，从而为自适应復健计画提供资讯。因此，临床医生开始将远距心电图监测、多参数趋势分析和脉搏血氧计回馈纳入标准化通讯协定，以支持从偶发性评估到持续结果追踪的过渡。

同时，復健设备製造商正在重新考虑外形规格和易用性，以支持在家中安全、无人监督的使用。携带式自行车测功仪和紧凑型跑步机正在整合曾经仅用于临床环境的安全和远端监控功能。治疗设备也正在与远端医疗工作流程相整合，电刺激和呼吸治疗模式现在以协作方案的形式提供，并由虚拟指导和临床医生监督支援。此类产品层面的创新正在推动新的服务模式，这些模式强调远端监控服务、远端医疗咨询和主动维护合约。

最后，监管途径和报销框架开始反映出向混合康復的转变。付款方越来越容易接受与降低再入院率和改善功能结果相关的证据，监管机构也正在明确对软体更新、资料安全和设备互通性的期望。这些变化正在加速远距復健的采用，促进设备製造商和数位医疗服务提供者之间的伙伴关係，并鼓励卫生系统试行大规模远距復健计画。

针对 2025 年美国关税变化进行商业性和营运调整，强调供应弹性、模组化设计和捆绑服务策略

美国近期针对2025年的贸易和关税发展，为心臟復健和监测设备製造商、供应商和医疗系统采购商带来了新的商业性考量。供应链相关人员正在重新评估感测器模组、电源管理IC和专用復健机械等关键组件的采购决策，以降低成本风险并保持生产的连续性。为此，一些设备製造商正在实现组件采购多元化，调整材料清单，并与战略供应商签订长期合同，以应对潜在的关税相关成本波动。

在采购调整的同时，製造商透过模组化产品架构和增加相容子系统的使用，加快了供应弹性的设计。这种方法降低了单一来源的脆弱性，并加快了供应商的重新认证流程。此外，拥有全球製造地的製造商正在策略性地将生产转移到贸易条件优惠的国家或更靠近终端市场的国家，以缩短前置作业时间并降低物流风险。对于医疗系统和采购部门而言，这种转变凸显了总拥有成本分析的重要性，该分析不仅考虑采购价格，还考虑物流、维护和备件供应情况。

最后，服务和软体元件作为价值槓桿正日益受到关注。远端监控服务和远端保健支援的维护合约有助于平滑收益影响，并为买家提供可预测的成本结构。因此，商业谈判越来越注重包含设备、软体和持续服务的捆绑产品，以便在瞬息万变的交易环境中确保临床的连续性和财务可预测性。

将设备模式、护理环境和服务连结起来的多维细分观点揭示了临床价值和采购优先顺序的交汇点

细緻的细分框架明确了临床影响和机会最集中的领域。就产品类型而言，市场细分为监测、復健和治疗设备。监测设备包括血压计、心电图监测仪、多参数监测仪和脉动式血氧监测仪系统，每种设备在復健工作流程中都发挥独特的监测和分类作用。復健设备包括臂式测功仪、自行车测功仪和跑步机，并根据治疗目标、患者活动需求和空间考量而有所不同。治疗设备包括电刺激、呼吸疗法和超音波疗法，每种设备都为康復和功能恢復提供特定于模式的益处。

从最终用户的角度来看，诊所、居家医疗机构、医院和復健中心是部署设备的主要医疗保健环境。在诊所中，心臟復健诊所和物理治疗诊所有不同的临床通讯协定和采购偏好。同时，在居家照护环境中，看护者辅助和自我管理场景对易用性和远端监控的要求也有所不同。医院和復健中心通常优先考虑与电子健康记录和集中监控平台的集成，强调互通性和临床医生工作流程的效率。

服务细分进一步明确了商业模式，区分了维护和支援服务、远端监控服务和远端医疗服务。维护和支援服务通常采用年度服务合约或按事件付费协议的形式，为买家提供不同程度的可预测性。远端监控服务涵盖数据分析和即时警报等多种服务，支援主动的临床介入。远端医疗服务包括远距指导和虚拟会诊，扩大临床医生的可近性并支持患者坚持用药。产品类型、最终用户和服务这三个维度的结合，为整个心臟復健生态系统的需求驱动因素和采购决策提供了多维度的观点。

区域采用模式和政策主导的优先事项决定了临床整合、采购偏好和全球市场部署的可行性

区域动态正在塑造各主要地区不同的采用曲线和投资重点。在美洲，医疗系统正在试验混合护理模式，并强调以结果为导向的主导，优先考虑能够降低再入院率并改善患者报告结果的解决方案。因此，能够将监测数据整合到临床工作流程和计费系统中的设备供应商正获得更大的关注。同时，北美的报销趋势和私人付款人计划继续影响具有商业性可行性的远端医疗和远端监测服务的类型。

多样化的监管环境和参差不齐的医疗基础设施水平，使得欧洲、中东和非洲地区呈现出高度分化的格局。西欧市场正经历远端医疗与居家復健的快速融合，同时人们对资料保护和医疗设备监管寄予厚望；而该地区的新兴市场则优先考虑经济高效、性能强大的设备，以应对门诊病人和社区医疗资源的限制。在许多欧洲、中东和非洲地区，公共卫生倡议和区域伙伴关係正在推动试验计画，评估可扩展的远距復健作为扩大医疗覆盖范围的一种手段。

亚太地区既有患者数量庞大、正在采用先进数位医疗模式的都市区，也有人口众多、注重价格实惠、耐用设备的农村地区。在亚太地区的多个市场，政府正在投资远端医疗基础设施，并奖励能够减轻医院负担的数位解决方案。综合来看，这些区域模式揭示了製造商、通路合作伙伴和服务提供者在努力根据当地临床工作流程、报销环境和部署实际情况调整产品功能时所采取的细分策略。

硬体、软体和服务整合的竞争动态有利于互通性、网路安全性和以结果为中心的伙伴关係关係

心臟復健设备领域的竞争态势体现在老牌医疗设备製造商、专业復健设备製造商以及新兴数位医疗参与企业的混合竞争。传统设备製造商通常利用成熟的临床关係、广泛的服务网络和监管专业知识，在医院和机构管道中保持存在。这些老牌厂商正越来越多地与软体公司和远端医疗提供者合作，在其设备组合中增加远端监控和虚拟护理功能，从而扩大售后服务收益并提高临床连续性。

同时，敏捷的新兴企业和软体优先型公司正在透过专注于使用者体验、数据分析和快速迭代来颠覆传统的价值提案。这些参与企业通常与付款方和综合医疗系统合作进行试点，检验结果并证明成本效益，然后透过合作伙伴关係和许可协议进行扩展。通路合作伙伴和服务提供者在推动采用、提供安装、临床医生培训、持续设备管理等方面发挥核心作用。此外，契约製造製造商和全球供应商在管理组件可用性和加快产品迭代周期方面也发挥着至关重要的作用。

策略差异化取决于能否提供整合提案，将可靠的硬体、安全的资料流和可操作的临床工作流程融为一体。能够展现互通性、强大的网路安全实务和检验的临床路径的公司，更有可能获得采购委员会的更多认可。同时，投资于可扩展服务模式（例如远端监控订阅和结果主导的维护）的公司，将能够建立永续的经常性收益来源并深化客户关係。

设备製造商和服务供应商应优先考虑的策略槓桿，以推动可扩展的采用、供应弹性和临床检验的价值提案

产业领导者应优先考虑能够加速安全、可扩展部署并增强商业性韧性的策略。首先，采用模组化架构和清晰的互通性标准设计产品，可以减少与医院IT系统的整合摩擦，并支援在各种临床环境中快速采用。此外，强调强大的网路安全、资料管治和合规框架对于与临床医生和医疗系统买家建立信任也至关重要。

其次，领导者应扩展服务范围，并将设备与远端监控、远端医疗指导和分级维护合约捆绑在一起，以协调供应商和购买者之间的奖励。捆绑式解决方案可以透过产生可预测的业务收益并提高客户维繫来降低资费和物流的不确定性。第三，透过可操作的临床研究和真实世界证据计画投资于证据生成，可以强化价值提案，并简化与付款人的报销谈判。这些研究应着重于功能结果、依从性指标和健康经济影响，以引起决策者的共鸣。

最后，追求灵活的生产布局和多元化的供应链，可以降低贸易中断和零件短缺的风险。与数位医疗公司、本地经销商和临床领导者建立策略伙伴关係，可以加速市场准入，并支援培训和支援的在地化。透过执行这些优先事项，产业相关人员可以改善患者治疗效果，减少医疗保健提供者的营运摩擦，并在动态环境中建立可防御的商业模式。

调查方法结合二手文献、监管调查和相关人员访谈，提供可行的见解并检验医疗设备趋势

本分析的基础研究将系统性的二次研究与有针对性的一次研究相结合，以确保研究的稳健性和实践相关性。二次研究包括对同行评审的临床文献、监管指南文件、医疗设备技术标准以及公共卫生机构关于远端医疗和远端监控的声明的全面回顾。这项基础研究揭示了有关设备模式、临床最佳实践和监管现状的事实，并补充了过时的产品摘要和技术规格，为近期的产品创新提供了背景资讯。

主要研究活动包括对临床医生、生物医学工程师、采购专家以及医疗机构高管进行结构化访谈，以了解目前采用该技术的驱动因素、工作流程限制和服务偏好。访谈对象特意来自医院、復健中心、诊所和居家照护机构，以反映采用情况的多样性。此外，与设备设计师和供应链经理进行的技术咨询，提供了关于组件采购、製造权衡以及在传统临床环境之外部署的设计策略的见解。

资料合成包括将访谈中获得的定性见解与二手证据进行三角检验，以检验新出现的主题。品管包括访谈结果的交叉检验、专家反覆评审以及与监管指南的一致性检查。在整个过程中，调查方法透明度和伦理考量指南资料收集，确保受访者的隐私和结论的完整性。

整合技术、临床和商业性需求，定义可扩展混合心臟復健模式的道路

心臟復健设备及相关服务正在重塑患者的康復，透过实现持续监测、将临床医生的监督延伸至诊所之外以及支持个人化治疗方法。监测设备、復健设备和治疗模式之间的相互作用，结合远端监测和远端医疗服务，创建了一体化的护理路径，从而提高了依从性并简化了临床医生的工作流程。儘管由于基础设施和政策环境的不同，各地区最合适的配置也存在差异，但混合型、数据主导復健的基本趋势始终保持一致。

商业性，供应链的韧性、对服务主导经营模式的投资以及临床价值的清晰展示将使市场参与企业脱颖而出。监管的一致性和互通性对于更广泛的应用仍然至关重要，而可操作证据的产生将有助于报销讨论和临床认可。随着相关人员重塑采购和医疗服务交付方式，对于那些能够平衡设备可靠性、软体驱动的医疗协调和可扩展服务营运的创新者来说，存在着明显的机会。

摘要，设备创新、数位化服务和照护模式重塑的融合，为改善心臟復健结果提供了一条持久的途径。那些能够深思熟虑地整合这些要素，同时管理营运和监管复杂性的机构，将能够引领这个不断发展的生态系统。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 透过整合穿戴式感测器数据和人工智慧指导，扩展针对心臟病发作后患者的远距復健平台
  • 实施具有即时心电图分析功能的远端患者监护系统，以便在復健期间及早发现心臟异常
  • 开发结合虚拟实境锻炼模组和游戏化的家庭数位疗法，以促进患者遵守復健计划
  • 将区块链保护的患者记录整合到心臟復健设备中，以增强医疗保健提供者之间的资料隐私和互通性
  • 增加对可携式低功耗心臟辅助设备的投资，以实现远端、连续的血流动力学监测和个人化运动处方

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 心臟復健设备市场（依产品类型）

  • 监控设备
    • 血压计
    • 心电图监测仪
    • 多参数监视器
    • 脉动式血氧监测仪系统
  • 復健设备
    • 臂力计
    • 自行车测功仪
    • 跑步机
  • 治疗设备
    • 电刺激设备
    • 呼吸治疗装置
    • 超音波治疗仪

9. 心臟復健设备市场（依最终用户）

  • 诊所
    • 心臟復健诊所
    • 物理治疗诊所
  • 居家照护环境
    • 看护者支持
    • 自我管理
  • 医院
  • 復健中心

第 10 章：心臟復健设备市场（按服务）

  • 维护和支援
    • 年度服务协议
    • 按事件付费
  • 远端监控服务
    • 数据分析
    • 即时警报
  • 远端医疗服务
    • 远距辅导
    • 虚拟咨询

第 11 章：心臟復健设备市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 12 章：心臟復健设备市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 13 章：心臟復健设备市场（按国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • General Electric Company
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • Medtronic plc
    • Abbott Laboratories
    • Nihon Kohden Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Hill-Rom Holdings, Inc.
    • BioTelemetry, Inc.
    • Philips Healthcare
Product Code: MRR-433AB1DC2894

The Cardiac Rehabilitation Device Market is projected to grow by USD 4.87 billion at a CAGR of 8.34% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.56 billion
Estimated Year [2025] USD 2.78 billion
Forecast Year [2032] USD 4.87 billion
CAGR (%) 8.34%

Defining the evolving crossroads between clinical practice and connected rehabilitation technology that is reshaping patient recovery pathways in cardiology

Cardiac rehabilitation technology is at the intersection of medical device engineering, digital health, and patient-centered care. Recent innovation cycles have expanded the scope of devices beyond clinical settings, enabling continuous physiological monitoring, targeted therapeutic interventions, and increasingly sophisticated remote engagement. These advancements are complemented by parallel developments in data analytics, interoperability standards, and user-centered design, which together are reshaping how cardiology teams deliver rehabilitation across the continuum of care.

Transitioning from inpatient-centric rehabilitation paradigms to hybrid models that blend clinic-based supervision with home-based regimens has been enabled by monitoring devices such as ambulatory ECGs and multi-parameter platforms, as well as by rehabilitation equipment that is optimized for safe use outside hospital wards. At the same time, therapeutic devices including electrical stimulation and respiratory therapy tools are being adapted for scalable, supervised home use. This confluence of device miniaturization, connectivity, and remote service delivery is creating new pathways for improving adherence, reducing rehospitalization, and tailoring rehabilitation intensity to individual recovery trajectories.

Given these dynamics, stakeholders from clinical leaders to device developers are re-examining care pathways and procurement strategies. Payers and health systems are increasingly attentive to evidence demonstrating clinical outcomes and operational efficiencies. As a result, the cardiac rehabilitation device landscape is evolving rapidly, with implications for clinical protocols, purchasing decisions, and patient engagement models.

How sensor convergence, compact rehabilitation equipment, and evolving policy are accelerating hybrid cardiac rehab models and remote clinical oversight

The landscape of cardiac rehabilitation devices is undergoing transformative shifts driven by technological maturation, policy evolution, and care delivery redesign. At the technological level, convergence between sensor fidelity, battery efficiency, and real-time analytics has enabled monitoring devices to provide clinically meaningful data streams that can inform adaptive rehabilitation programs. Consequently, clinicians are beginning to incorporate remote ECG monitoring, multi-parameter trend analysis, and pulse oximetry feedback into standardized protocols, which supports a transition from episodic assessments to continuous outcome tracking.

Concurrently, rehabilitation equipment manufacturers are rethinking form factors and usability to support safe unsupervised use at home; portable cycle ergometers and compact treadmills now incorporate safety features and remote supervision capabilities that were once exclusive to clinical settings. Therapeutic devices are also becoming more integrated with telehealth workflows, so electrical stimulation and respiratory therapy modalities can be delivered in coordinated regimens supported by virtual coaching and clinician oversight. These product-level innovations are catalyzing new service models that emphasize remote monitoring services, telehealth consultations, and proactive maintenance agreements.

Finally, regulatory pathways and reimbursement frameworks are beginning to reflect the shift toward hybrid rehabilitation. Payers are more receptive to evidence of reduced readmissions and improved functional outcomes, while regulators are clarifying expectations for software updates, data security, and device interoperability. Together, these changes are accelerating adoption, encouraging partnerships between device makers and digital health providers, and prompting health systems to pilot scaled remote rehabilitation programs.

Commercial and operational adjustments in response to 2025 United States tariff shifts emphasizing supply resilience, modular design, and bundled service strategies

Recent trade and tariff developments in the United States in 2025 have introduced an additional layer of commercial calculus for manufacturers, suppliers, and health system purchasers of cardiac rehabilitation equipment and monitoring devices. Supply chain actors are reassessing sourcing decisions for key components such as sensor modules, power management ICs, and specialized rehabilitation mechanics to mitigate cost exposure and maintain manufacturing continuity. In response, several device makers have diversified component sourcing, adjusted bill-of-material allocations, and negotiated longer-term agreements with strategic suppliers to buffer against potential tariff-related cost fluctuations.

Parallel to procurement adjustments, manufacturers have accelerated design for supply resilience by modularizing product architectures and increasing the use of interchangeable subsystems. This approach reduces single-source vulnerability and enables faster supplier requalification processes. Moreover, manufacturers with global manufacturing footprints are strategically shifting production runs to jurisdictions with favorable trade terms or closer proximity to end markets to reduce lead times and logistical risk. For health systems and procurement offices, these shifts have elevated the importance of total cost of ownership analyses that account not only for purchase price but also for logistics, maintenance, and spare-part availability.

Finally, services and software components have gained attention as value levers; remote monitoring services and telehealth-enabled maintenance contracts help smooth revenue impacts and offer predictable cost structures for buyers. As a result, commercial negotiations increasingly emphasize bundled offerings that incorporate devices, software, and ongoing services to provide clinical continuity and fiscal predictability in a shifting trade environment.

A multi-dimensional segmentation perspective linking device modalities, care settings, and services to reveal where clinical value and procurement priorities intersect

A nuanced segmentation framework provides clarity on where clinical impact and commercial opportunity are most concentrated. When examining product type, the market differentiates between monitoring devices, rehabilitation equipment, and therapeutic devices. Monitoring devices encompass blood pressure monitors, ECG monitors, multi-parameter monitors, and pulse oximeters, each serving distinct monitoring and triage roles in rehabilitation workflows. Rehabilitation equipment spans arm ergometers, cycle ergometers, and treadmills, which differ by therapeutic focus, patient mobility requirements, and space considerations. Therapeutic devices include electrical stimulation devices, respiratory therapy devices, and ultrasound therapy devices, each offering modality-specific benefits for recovery and functional restoration.

In terms of end users, clinics, home care settings, hospitals, and rehabilitation centers represent the primary care environments where devices are deployed. Within clinics, cardiac rehabilitation clinics and physical therapy clinics present different clinical protocols and procurement preferences, while home care settings split between caregiver-assisted and self-administered scenarios that drive differing requirements for usability and remote supervision. Hospitals and rehabilitation centers often prioritize integration with electronic health records and centralized monitoring platforms, emphasizing interoperability and clinician workflow efficiency.

Service segmentation further clarifies commercial models, distinguishing maintenance and support services, remote monitoring services, and telehealth services. Maintenance and support can be structured as annual service contracts or pay-per-incident agreements, providing varying degrees of predictability for buyers. Remote monitoring services range from data analytics to real-time alerts, enabling proactive clinical interventions. Telehealth services include remote coaching and virtual consultations that extend clinician reach and support adherence. Together, these three lenses-product type, end user, and service-create a multi-dimensional view of demand drivers and procurement decision-making across the cardiac rehabilitation ecosystem.

Regional adoption patterns and policy-driven priorities that determine clinical integration, procurement preferences, and deployment feasibility across global markets

Regional dynamics are shaping adoption curves and investment priorities in distinct ways across major geographies. In the Americas, health systems are experimenting with hybrid care models and placing emphasis on outcome-driven procurement, which favors solutions that demonstrate reductions in rehospitalization and improvements in patient-reported outcomes. As a result, device providers that can integrate monitoring data into clinical workflows and billing systems are achieving greater traction. Meanwhile, North American reimbursement trends and private payer programs continue to influence the types of telehealth and remote monitoring services that are commercially viable.

In Europe, Middle East & Africa, diverse regulatory environments and varying levels of healthcare infrastructure produce a heterogeneous landscape. Western European markets are advancing rapid integration of telemetry and home-based rehabilitation with strong data protection and medical device regulatory expectations, while emerging markets within the region are prioritizing cost-effective, robust devices that address capacity constraints in outpatient and community settings. In many EMEA jurisdictions, public health initiatives and regional partnerships are driving pilot programs that assess scalable remote rehabilitation as a means to broaden access.

Asia-Pacific presents a combination of high-volume urban centers adopting advanced digital health models and large rural populations where low-cost, durable devices are prioritized. Governments in several APAC markets are investing in telehealth infrastructure and incentivizing digital solutions that decrease hospital burden. Collectively, these regional patterns inform segmentation strategies for manufacturers, channel partners, and service providers seeking to match product capabilities to local clinical workflows, reimbursement environments, and deployment realities.

Competitive landscape dynamics driven by integration of hardware, software, and services that favor interoperability, cybersecurity, and outcome-focused partnerships

Competitive dynamics within the cardiac rehabilitation device sector are characterized by a mix of established medical device manufacturers, specialized rehabilitation equipment producers, and emergent digital health entrants. Legacy device manufacturers typically leverage established clinical relationships, broad service networks, and regulatory expertise to maintain presence in hospital and institutional channels. These incumbents are increasingly partnering with software firms and telehealth providers to add remote monitoring and virtual care capabilities to their device portfolios, thereby extending after-sales revenue and improving clinical continuity.

At the same time, agile startups and software-first companies are disrupting traditional value propositions by focusing on user experience, data analytics, and rapid iteration. These entrants often pilot with payers and integrated health systems to validate outcomes and prove cost-effectiveness, then scale through partnerships or licensing arrangements. Channel partners and service providers play a central role in enabling adoption, offering installation, clinician training, and ongoing device management. Additionally, contract manufacturers and global suppliers are critical in managing component availability and enabling faster product iteration cycles.

Strategic differentiation increasingly rests on the ability to deliver integrated propositions that combine reliable hardware, secure data flows, and actionable clinical workflows. Companies that can demonstrate interoperability, robust cybersecurity practices, and validated clinical pathways will find greater openness from procurement committees. Meanwhile, those that invest in scalable service models-such as remote monitoring subscriptions and outcome-driven maintenance-can create sustainable recurring revenue streams and deepen customer relationships.

Prioritized strategic levers for device makers and service providers to drive scalable adoption, supply resilience, and clinically validated value propositions

Industry leaders should prioritize strategies that accelerate safe, scalable deployment while strengthening commercial resilience. Firstly, designing products with modular architectures and clear interoperability standards will reduce integration friction with hospital IT systems and support faster adoption across varied clinical environments. Emphasizing robust cybersecurity, data governance, and compliance frameworks will also be essential to building trust with clinicians and health system purchasers.

Secondly, leaders should expand service offerings to bundle devices with remote monitoring, telehealth coaching, and tiered maintenance contracts that align incentives between providers and purchasers. Bundled solutions can mitigate tariff and logistics uncertainties by creating predictable service revenues and improving client retention. Thirdly, investing in evidence generation-through pragmatic clinical studies and real-world evidence programs-will strengthen value propositions and simplify reimbursement discussions with payers. These studies should focus on functional outcomes, adherence metrics, and health economic impacts to resonate with decision-makers.

Finally, pursuing flexible manufacturing footprints and diversified supply chains can reduce exposure to trade disruptions and component shortages. Strategic partnerships with digital health firms, local distributors, and clinical leaders will accelerate market entry and support localization of training and support. By executing on these priorities, industry participants can enhance patient outcomes, reduce operational friction for care providers, and create defensible commercial models in a dynamic landscape.

A methodologically rigorous approach combining secondary literature, regulatory review, and targeted stakeholder interviews to validate practical insights and device trends

The research underpinning this analysis combines systematic secondary review with targeted primary investigations to ensure robustness and practical relevance. Secondary activities included a comprehensive review of peer-reviewed clinical literature, regulatory guidance documents, technical standards for medical devices, and public statements from health authorities governing telehealth and remote monitoring. This foundation established the factual landscape of device modalities, clinical best practices, and regulatory expectations, which was then supplemented with dated product briefs and technical specifications to contextualize recent product innovations.

Primary research activities incorporated structured interviews with clinicians, biomedical engineers, procurement specialists, and senior executives across care settings to capture current adoption drivers, workflow constraints, and service preferences. Interviews were purposefully sampled across hospitals, rehabilitation centers, clinics, and home care providers to reflect the diversity of deployment contexts. In addition, technical consultations with device designers and supply chain managers provided insight into component sourcing, manufacturing trade-offs, and design strategies that address deployment outside traditional clinical environments.

Data synthesis relied on triangulating qualitative insights from interviews with secondary evidence to validate emerging themes. Quality controls included cross-validation of interview findings, iterative review by subject matter experts, and alignment checks against regulatory guidance. Throughout the process, methodological transparency and ethical considerations guided data collection, ensuring respondent confidentiality and the integrity of conclusions.

Synthesis of technological, clinical, and commercial imperatives that together define the pathway to scalable, hybrid cardiac rehabilitation models

Cardiac rehabilitation devices and their associated services are reshaping patient recovery by enabling continuous monitoring, extending clinician oversight beyond clinic walls, and supporting personalized therapeutic regimens. The interplay between monitoring devices, rehabilitation equipment, and therapeutic modalities-when combined with remote monitoring and telehealth services-creates integrated care pathways that can improve adherence and streamline clinician workflows. Across regions, different infrastructure and policy environments influence which configurations are most appropriate, but the underlying trajectory toward hybrid, data-driven rehabilitation is consistent.

Commercially, resilience in supply chains, investment in service-led business models, and clear demonstration of clinical value will differentiate successful market participants. Regulatory alignment and interoperability will remain crucial for broader adoption, while pragmatic evidence generation will support reimbursement discussions and clinical acceptance. As stakeholders reconfigure procurement and care delivery approaches, there is a clear opportunity for innovators who balance device reliability with software-enabled care coordination and scalable service operations.

In summary, the convergence of device innovation, digital services, and care model redesign presents a durable pathway to improve cardiac rehabilitation outcomes. Organizations that act thoughtfully to integrate these elements, while managing operational and regulatory complexity, will be positioned to lead in this evolving ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of tele-rehabilitation platforms integrating wearable sensor data and AI-guided coaching for post-heart event patients
  • 5.2. Adoption of remote patient monitoring systems with real-time ECG analysis for early detection of cardiac anomalies during rehab sessions
  • 5.3. Development of home-based digital therapeutics combining virtual reality exercise modules and gamification to boost patient adherence to rehab regimens
  • 5.4. Integration of blockchain-secured patient records in cardiac rehab devices to enhance data privacy and interoperability across healthcare providers
  • 5.5. Growing investment in portable low-power cardiac assist devices enabling continuous hemodynamic monitoring and personalized exercise prescriptions remotely

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Rehabilitation Device Market, by Product Type

  • 8.1. Monitoring Devices
    • 8.1.1. Blood Pressure Monitors
    • 8.1.2. EcG Monitors
    • 8.1.3. Multi-Parameter Monitors
    • 8.1.4. Pulse Oximeters
  • 8.2. Rehabilitation Equipment
    • 8.2.1. Arm Ergometer
    • 8.2.2. Cycle Ergometers
    • 8.2.3. Treadmills
  • 8.3. Therapeutic Devices
    • 8.3.1. Electrical Stimulation Devices
    • 8.3.2. Respiratory Therapy Devices
    • 8.3.3. Ultrasound Therapy Devices

9. Cardiac Rehabilitation Device Market, by End User

  • 9.1. Clinics
    • 9.1.1. Cardiac Rehab Clinics
    • 9.1.2. Physical Therapy Clinics
  • 9.2. Home Care Settings
    • 9.2.1. Caregiver-Assisted
    • 9.2.2. Self-Administered
  • 9.3. Hospitals
  • 9.4. Rehabilitation Centers

10. Cardiac Rehabilitation Device Market, by Service

  • 10.1. Maintenance And Support
    • 10.1.1. Annual Service Contracts
    • 10.1.2. Pay-Per-Incident
  • 10.2. Remote Monitoring Services
    • 10.2.1. Data Analytics
    • 10.2.2. Real-Time Alerts
  • 10.3. Telehealth Services
    • 10.3.1. Remote Coaching
    • 10.3.2. Virtual Consultations

11. Cardiac Rehabilitation Device Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Cardiac Rehabilitation Device Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Cardiac Rehabilitation Device Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. General Electric Company
    • 14.3.2. Koninklijke Philips N.V.
    • 14.3.3. Siemens Healthineers AG
    • 14.3.4. Medtronic plc
    • 14.3.5. Abbott Laboratories
    • 14.3.6. Nihon Kohden Corporation
    • 14.3.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 14.3.8. Hill-Rom Holdings, Inc.
    • 14.3.9. BioTelemetry, Inc.
    • 14.3.10. Philips Healthcare

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. CARDIAC REHABILITATION DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. CARDIAC REHABILITATION DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CARDIAC REHABILITATION DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TY